Overall, while BAFF stands out as a significant factor in modulating B-cell activity and influencing inflammation in SS, APRIL appears to have a subtler role, warranting further investigation to clarify its function and therapeutic potential in managing salivary gland involvement in this autoimmune condition. Here, TNFSF13 is linked to synovial sarcoma.